Sorry, but that, again, is a lot of sound and fury signifying nothing. Yes, they will look for consistency across subgroups, but they're not going to care one whit about proof of the exact MOA, and I doubt they will place much emphasis on PK/PD. It's all about whether or not 9902A can be considered supportive, and if the survival dataset is sufficiently large.